Iranian Multi-center Osteoporosis Study (IMOS), 2021-2022: the study protocol.
Kazem KhalagiNoushin FahimfarFatemeh HajivalizadehMahnaz SanjariMohammad Javad MansourzadehSafoora GharibzadehGita ShafieeKoorosh KamaliFarshid AlaeddiniFarshad FarzadfarSamaneh MohseniNazli NamaziFarideh RaziKobra GorganiKatayoun Kateb SaberNekoo PanahiRamin HeshmatAlireza RaeisiBagher LarijaniAfshin OstovarPublished in: BMC geriatrics (2022)
IMOS will provide valuable information on the prevalence and determinants of osteoporosis and sarcopenia at the national level, and the results can be used in evaluating health system interventions and policymaking in the field of musculoskeletal diseases.